- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x HEJ: 9-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}-9H-purin-6-amine(Non-covalent)
- 4 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
GTP.2: 16 residues within 4Å:- Chain A: Y.79, V.80, V.302, R.375, K.379
- Chain C: K.447
- Chain D: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Ligands: DTP.21, MG.32
15 PLIP interactions:9 interactions with chain D, 4 interactions with chain A, 2 interactions with chain C- Hydrogen bonds: D:V.41, D:Q.66, D:R.69
- Water bridges: D:K.40, D:K.40
- Salt bridges: D:K.40, D:K.40, D:K.40, D:D.61, A:R.375, A:K.379, A:K.379, C:K.447, C:K.447
- pi-Cation interactions: A:R.375
GTP.5: 16 residues within 4Å:- Chain A: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Chain B: K.447
- Chain D: Y.79, V.80, V.302, R.375, K.379
- Ligands: MG.4, DTP.15
15 PLIP interactions:8 interactions with chain A, 5 interactions with chain D, 2 interactions with chain B- Hydrogen bonds: A:V.41, A:Q.66, A:R.69
- Water bridges: A:D.61
- Salt bridges: A:K.40, A:K.40, A:K.40, A:D.61, D:K.301, D:R.375, D:K.379, D:K.379, B:K.447, B:K.447
- pi-Cation interactions: D:R.375
GTP.13: 16 residues within 4Å:- Chain B: Y.79, V.80, V.302, R.375, K.379
- Chain C: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Chain D: K.447
- Ligands: MG.22, DTP.33
17 PLIP interactions:2 interactions with chain D, 10 interactions with chain C, 5 interactions with chain B- Salt bridges: D:K.447, D:K.447, C:K.40, C:K.40, C:K.40, C:D.61, B:R.375, B:K.379, B:K.379
- Hydrogen bonds: C:V.41, C:Q.66, C:R.69, C:R.69, B:R.375
- Water bridges: C:K.40, C:K.40
- pi-Cation interactions: B:R.375
GTP.24: 16 residues within 4Å:- Chain A: K.447
- Chain B: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Chain C: Y.79, V.80, V.302, R.375, K.379
- Ligands: DTP.3, MG.14
14 PLIP interactions:7 interactions with chain B, 5 interactions with chain C, 2 interactions with chain A- Hydrogen bonds: B:V.41, B:Q.66, B:R.69, C:R.375
- Salt bridges: B:K.40, B:K.40, B:K.40, B:D.61, C:R.375, C:K.379, C:K.379, A:K.447, A:K.447
- pi-Cation interactions: C:R.375
- 4 x DTP: 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE(Non-covalent)
DTP.3: 19 residues within 4Å:- Chain A: R.257, F.261, R.276, K.278, N.282, K.447
- Chain B: V.41, I.42, N.43, H.49
- Chain C: V.80, F.81, I.249, R.296, H.300, K.301, V.302
- Ligands: MG.14, GTP.24
20 PLIP interactions:10 interactions with chain A, 8 interactions with chain C, 2 interactions with chain B- Hydrogen bonds: A:R.257, A:N.282, C:R.296, B:N.43, B:N.43
- Salt bridges: A:R.257, A:R.276, A:K.278, A:K.278, A:K.278, A:K.447, C:H.300, C:H.300, C:K.301, C:K.301, C:K.301
- pi-Cation interactions: A:R.257, A:R.257
- Hydrophobic interactions: C:V.80, C:F.81
DTP.15: 19 residues within 4Å:- Chain A: V.41, I.42, N.43, H.49
- Chain B: R.257, F.261, R.276, K.278, N.282, K.447
- Chain D: V.80, F.81, I.249, R.296, H.300, K.301, V.302
- Ligands: MG.4, GTP.5
21 PLIP interactions:7 interactions with chain D, 12 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: D:V.80, D:F.81
- Salt bridges: D:H.300, D:H.300, D:K.301, D:K.301, D:K.301, B:R.257, B:R.276, B:K.278, B:K.278, B:K.278, B:K.447
- Hydrogen bonds: B:R.257, B:N.282, B:N.282, A:N.43, A:N.43
- Water bridges: B:D.254
- pi-Cation interactions: B:R.257, B:R.257
DTP.21: 19 residues within 4Å:- Chain A: V.80, F.81, I.249, R.296, H.300, K.301, V.302
- Chain C: R.257, F.261, R.276, K.278, N.282, K.447
- Chain D: V.41, I.42, N.43, H.49
- Ligands: GTP.2, MG.32
21 PLIP interactions:12 interactions with chain C, 7 interactions with chain A, 2 interactions with chain D- Hydrogen bonds: C:R.257, C:R.257, C:N.282, C:N.282, D:N.43, D:N.43
- Salt bridges: C:R.257, C:R.276, C:K.278, C:K.278, C:K.278, C:K.447, A:H.300, A:H.300, A:K.301, A:K.301, A:K.301
- pi-Cation interactions: C:R.257, C:R.257
- Hydrophobic interactions: A:V.80, A:F.81
DTP.33: 19 residues within 4Å:- Chain B: V.80, F.81, I.249, R.296, H.300, K.301, V.302
- Chain C: V.41, I.42, N.43, H.49
- Chain D: R.257, F.261, R.276, K.278, N.282, K.447
- Ligands: GTP.13, MG.22
20 PLIP interactions:7 interactions with chain B, 11 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: B:V.80, B:F.81
- Salt bridges: B:H.300, B:H.300, B:K.301, B:K.301, B:K.301, D:R.257, D:R.276, D:K.278, D:K.278, D:K.278, D:K.447
- Hydrogen bonds: D:R.257, D:N.282, D:N.282, C:N.43, C:N.43
- pi-Cation interactions: D:R.257, D:R.257
- 10 x MG: MAGNESIUM ION(Non-covalent)
MG.4: 3 residues within 4Å:- Chain A: K.40
- Ligands: GTP.5, DTP.15
No protein-ligand interaction detected (PLIP)MG.6: 3 residues within 4Å:- Chain A: D.233, K.236
- Ligands: HEJ.1
No protein-ligand interaction detected (PLIP)MG.7: 5 residues within 4Å:- Chain A: K.72, Q.73, L.74, A.84, H.86
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:A.84, A:H.86
MG.14: 3 residues within 4Å:- Chain B: K.40
- Ligands: DTP.3, GTP.24
No protein-ligand interaction detected (PLIP)MG.16: 3 residues within 4Å:- Chain B: D.233, K.236
- Ligands: HEJ.12
No protein-ligand interaction detected (PLIP)MG.22: 3 residues within 4Å:- Chain C: K.40
- Ligands: GTP.13, DTP.33
No protein-ligand interaction detected (PLIP)MG.25: 3 residues within 4Å:- Chain C: D.233, K.236
- Ligands: HEJ.23
No protein-ligand interaction detected (PLIP)MG.32: 4 residues within 4Å:- Chain C: K.447
- Chain D: K.40
- Ligands: GTP.2, DTP.21
No protein-ligand interaction detected (PLIP)MG.35: 5 residues within 4Å:- Chain D: K.72, Q.73, L.74, A.84, H.86
2 PLIP interactions:2 interactions with chain D- Metal complexes: D:A.84, D:H.86
MG.36: 3 residues within 4Å:- Chain D: D.233, K.236
- Ligands: HEJ.34
No protein-ligand interaction detected (PLIP)- 17 x NA: SODIUM ION(Non-functional Binders)
NA.8: 5 residues within 4Å:- Chain A: H.134, G.135, S.138, F.141, D.142
Ligand excluded by PLIPNA.9: 3 residues within 4Å:- Chain A: H.47, Y.255, K.256
Ligand excluded by PLIPNA.10: 6 residues within 4Å:- Chain A: P.82, G.83, S.85
- Chain D: H.86, E.90, H.246
Ligand excluded by PLIPNA.11: 5 residues within 4Å:- Chain A: D.37, T.38, P.54, V.57, R.58
Ligand excluded by PLIPNA.17: 6 residues within 4Å:- Chain B: P.82, G.83, S.85
- Chain C: H.86, E.90, H.246
Ligand excluded by PLIPNA.18: 2 residues within 4Å:- Chain B: A.241, H.245
Ligand excluded by PLIPNA.19: 6 residues within 4Å:- Chain B: Y.431, G.432, M.433, Q.434, K.436, F.469
Ligand excluded by PLIPNA.20: 2 residues within 4Å:- Chain B: R.290, D.430
Ligand excluded by PLIPNA.26: 2 residues within 4Å:- Chain C: H.288, Y.431
Ligand excluded by PLIPNA.27: 5 residues within 4Å:- Chain C: K.72, Q.73, L.74, A.84, H.86
Ligand excluded by PLIPNA.28: 3 residues within 4Å:- Chain C: Y.284, Y.431, P.466
Ligand excluded by PLIPNA.29: 4 residues within 4Å:- Chain C: E.223, N.227, N.230, I.273
Ligand excluded by PLIPNA.37: 7 residues within 4Å:- Chain A: N.43, P.45
- Chain D: F.81, P.82, G.83, H.246, L.247
Ligand excluded by PLIPNA.38: 2 residues within 4Å:- Chain D: A.241, H.245
Ligand excluded by PLIPNA.39: 6 residues within 4Å:- Chain A: H.86, E.90, H.246
- Chain D: P.82, G.83, S.85
Ligand excluded by PLIPNA.40: 3 residues within 4Å:- Chain D: H.47, Y.255, K.256
Ligand excluded by PLIPNA.41: 4 residues within 4Å:- Chain B: K.504, Q.506
- Chain D: R.455, Q.460
Ligand excluded by PLIP- 1 x GLY: GLYCINE(Non-covalent)
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Knecht, K.M. et al., The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-10-24
- Peptides
- Deoxynucleoside triphosphate triphosphohydrolase SAMHD1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
CC
BD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x HEJ: 9-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}-9H-purin-6-amine(Non-covalent)
- 4 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 4 x DTP: 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE(Non-covalent)
- 10 x MG: MAGNESIUM ION(Non-covalent)
- 17 x NA: SODIUM ION(Non-functional Binders)
- 1 x GLY: GLYCINE(Non-covalent)
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Knecht, K.M. et al., The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-10-24
- Peptides
- Deoxynucleoside triphosphate triphosphohydrolase SAMHD1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
CC
BD
A